It's very well comprehended that IL-two is usually a pleiotropic cytokine positioned at the crossroads of T cell activation and regulation. As a result, it can be critical to engineer an IL-2 molecule that is definitely biased toward effector cells bearing the intermediate affinity receptor, like naïve and memory CD8+ T cells and NK cells, versus